Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

48
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
48
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

41
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
41
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

77
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
77
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

53
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
53
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

71
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
71
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

69
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical thrombectomy in intermediate-high risk pulmonary embolism: progress, promise, and remaining uncertainty.

Journal of thoracic disease·2026
Same author

Correction to: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/ SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

Pulmonary Embolism-Attributable Mortality in Patients With Heart Failure in the United States, 2010 to 2020.

JACC. Advances·2026
Same author

Clinical and Echocardiographic Factors Associated With Left Ventricular Thrombus Recurrence.

JACC. Advances·2026
Same author

Arteriopathy of the Internal Mammary Artery: Implications for Patients With Spontaneous Coronary Artery Dissection.

JACC. Case reports·2026
Same author

Society Communications: Practice Tools for VTE Care and Highlights from the 2026 Fellows/APP Course.

Vascular medicine (London, England)·2026

Related Experiment Video

Updated: Oct 15, 2025

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
04:56

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

205

Thoracic Aortic Aneurysm: A Clinical Review.

Ethan M Senser1, Shantum Misra2, Stanislav Henkin1

  • 1Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA.

Cardiology Clinics
|October 23, 2021
PubMed
Summary

Thoracic aortic aneurysms (TAAs) are common, often asymptomatic, and linked to genetic factors. Early detection via imaging and diameter monitoring, alongside lifestyle changes and timely repair, are key to reducing TAA mortality.

Keywords:
Bicuspid aortic valveLoeys-Dietz syndromeMarfan syndromeThoracic aortic aneurysmThoracic aortic dissectionVascular Ehlers-Danlos syndrome

More Related Videos

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

532
Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

1.1K

Related Experiment Videos

Last Updated: Oct 15, 2025

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
04:56

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

205
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

532
Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

1.1K

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Radiology

Background:

  • Thoracic aortic aneurysms (TAAs) are prevalent vascular conditions.
  • Most TAAs are degenerative, but genetic factors, connective tissue disorders, and bicuspid aortic valves are also implicated.
  • Many TAAs are asymptomatic and found incidentally during imaging.

Purpose of the Study:

  • To provide a practical, evidence-based summary of TAA pathophysiology, risk factors, and management.
  • To highlight key predictors of TAA natural history and complication risk.
  • To inform clinical decision-making for TAA surveillance and intervention.

Main Methods:

  • Review of current evidence on TAA etiology and progression.
  • Analysis of diagnostic imaging findings and risk stratification.
  • Synthesis of guidelines for medical management and surgical referral.

Main Results:

  • Aortic diameter is the primary predictor of TAA outcomes.
  • Hypertension management and smoking cessation can slow aneurysm growth.
  • Surveillance imaging and prophylactic repair based on diameter reduce TAA mortality.

Conclusions:

  • Effective TAA management relies on understanding risk factors and monitoring aneurysm size.
  • Proactive medical and surgical interventions are crucial for preventing life-threatening complications.
  • Genetic counseling and screening may be indicated for individuals with a family history of TAAs.